|
antimicrobials |
5 |
|
apoptosis |
4 |
|
chlorhexidine |
4 |
|
herbal medicine |
4 |
|
metastasis |
4 |
|
nanotechnology |
4 |
|
oral biofilms |
4 |
|
rehmannia glutinosa |
4 |
|
scutellaria baicalensis |
4 |
|
traditional chinese medicine |
4 |
|
anti-inflammation |
3 |
|
anti-inflammatory |
3 |
|
assessment |
3 |
|
astragali radix |
3 |
|
atopic dermatitis |
3 |
|
breast cancer |
3 |
|
chinese medicine |
3 |
|
coriolus versicolor |
3 |
|
curriculum |
3 |
|
danshen |
3 |
|
diabetic foot ulcer |
3 |
|
eriocalyxin b |
3 |
|
gallic acid |
3 |
|
gegen |
3 |
|
learning outcomes |
3 |
|
nf-κb |
3 |
|
polysaccharide |
3 |
|
pregnancy |
3 |
|
radix astragali |
3 |
|
radix rehmanniae |
3 |
|
rehmanniae radix |
3 |
|
safety |
3 |
|
wound healing |
3 |
|
zebrafish |
3 |
|
andrographis paniculata |
2 |
|
angelica sinensis |
2 |
|
angiogenesis |
2 |
|
anoikis |
2 |
|
anti-angiogenesis |
2 |
|
anti-metastasis |
2 |
|
anti-tumor |
2 |
|
anticonvulsant |
2 |
|
antiepileptic |
2 |
|
antitumor |
2 |
|
astragalus membranaceus |
2 |
|
astragalus polysaccharides |
2 |
|
bigelovin |
2 |
|
bioassay-guided fractionation |
2 |
|
botanicals |
2 |
|
cancer |
2 |
|
cancer recurrence |
2 |
|
cancer vaccine |
2 |
|
cell cycle arrest |
2 |
|
chinese herbal medicine |
2 |
|
chinese herbal medicines |
2 |
|
chinese medicines |
2 |
|
chuanxiong rhizoma |
2 |
|
colorectal cancer |
2 |
|
conjugate vaccine |
2 |
|
controlled corticalimpact |
2 |
|
cortex moutan |
2 |
|
cucurbitaceae |
2 |
|
curcuma longa |
2 |
|
curcumin |
2 |
|
cyclopeptide |
2 |
|
cytotoxic |
2 |
|
cytotoxicity |
2 |
|
da chuanxiong formula |
2 |
|
diabetes mellitus |
2 |
|
embryotoxicity |
2 |
|
endothelial cells |
2 |
|
epilepsy |
2 |
|
esophageal cancer |
2 |
|
estrogen receptor |
2 |
|
estrogenic herbs |
2 |
|
ganoderma sinense |
2 |
|
gastrodia elata blume |
2 |
|
gastrodiae rhizoma |
2 |
|
hedyotis corymbosa |
2 |
|
hedyotis diffusa |
2 |
|
hedyotiscone a |
2 |
|
herba epimedii |
2 |
|
herbal formula |
2 |
|
herbal medicines |
2 |
|
huvec |
2 |
|
huvecs |
2 |
|
inflammation |
2 |
|
isoandrographolide |
2 |
|
isodon eriocalyx |
2 |
|
leukemia |
2 |
|
mapks |
2 |
|
melamine |
2 |
|
methicillin-resistant staphylococcus aureus |
2 |
|
microencapsulation |
2 |
|
momordica charantia |
2 |
|
mrsa |
2 |
|
multidrug resistance |
2 |
|
murine wound infection model |
2 |
|
natural products |
2 |
|
neuroprotective effect |
2 |
|
nf3 |
2 |
|
p-glycoprotein |
2 |
|
p53 |
2 |
|
pancreatic cancer |
2 |
|
photodynamic therapy |
2 |
|
photosensitizers |
2 |
|
plant |
2 |
|
polysaccharides |
2 |
|
pueraria lobata |
2 |
|
quality control |
2 |
|
raw264.7macrophages |
2 |
|
reactive oxygen species |
2 |
|
rotarod |
2 |
|
rubinoboletus ballouii |
2 |
|
salvia miltiorrhiza |
2 |
|
saponin |
2 |
|
sars |
2 |
|
scutellaria barbata |
2 |
|
scutellarin |
2 |
|
stachyose |
2 |
|
synergism |
2 |
|
synergy |
2 |
|
tm4sf3 |
2 |
|
traumatic brain injury |
2 |
|
traumaticbraininjury |
2 |
|
tricin |
2 |
|
turmerone |
2 |
|
vasodilation |
2 |
|
verbascoside |
2 |
|
yunzhi |
2 |
|
zoledronic acid |
2 |
|
(lamp) |
1 |
|
1,2,3,4,6-penta-o-galloyl-β-d-glucose |
1 |
|
1-ribofuranosyl-s-triazin-2(1h)-one |
1 |
|
3-phenyl-2-propenoic acid |
1 |
|
3c-like protease |
1 |
|
4-hyroxyphenylacetate |
1 |
|
4-vinylphenol |
1 |
|
4t1 cells |
1 |
|
6-o-angeloylenolin |
1 |
|
8,9-didehydro-7-hydroxydolichodial |
1 |
|
abcg2 |
1 |
|
acanthopanacis senticosi radix et rhizoma seu caulis |
1 |
|
acanthopanax senticosus |
1 |
|
achyranthis bidentatae radix |
1 |
|
actein |
1 |
|
acute colitis |
1 |
|
adipogenesis |
1 |
|
adjunctive therapy |
1 |
|
agaricus blazei |
1 |
|
agricultural by-products |
1 |
|
air temperature condition |
1 |
|
airway epithelia |
1 |
|
allergic inflammation |
1 |
|
allergy |
1 |
|
allylation |
1 |
|
alpinia caerulea |
1 |
|
alpinia oxyphylla |
1 |
|
analytical high-speed counter-current chromatography |
1 |
|
anemarrhena asphodeloides |
1 |
|
angelicae sinensis radix |
1 |
|
angiogenic effect |
1 |
|
angpt2 |
1 |
|
anthraquinone |
1 |
|
anti-allergic |
1 |
|
anti-hiv |
1 |
|
anti-mycobacterial activity |
1 |
|
anti-osteolysis |
1 |
|
anti-osteoporotic herbal formula |
1 |
|
anti-resorptive agents |
1 |
|
anti-tumor agents |
1 |
|
anti-viral |
1 |
|
antiangiogenesis |
1 |
|
antibacteria |
1 |
|
antibacterial activity |
1 |
|
antibacterial photodynamic therapy (apdt) |
1 |
|
antibacterial potency |
1 |
|
antibody |
1 |
|
antidiabetics |
1 |
|
antifungal |
1 |
|
antigluconeogenic activity |
1 |
|
antimetastasis |
1 |
|
antimicrobial activity |
1 |
|
antimicrobial photodynamic therapy |
1 |
|
antimicrobial photodynamic therapy (apdt) |
1 |
|
antimycobacterial |
1 |
|
antioxidant |
1 |
|
antioxidant properties |
1 |
|
antitumour |
1 |
|
aorta |
1 |
|
apoptosis inducer |
1 |
|
aromatic-turmerone |
1 |
|
asperuloside |
1 |
|
aspirin |
1 |
|
asthma |
1 |
|
astragalosides |
1 |
|
astragalus |
1 |
|
astragalus membranaceus (fisch.) bge (am) |
1 |
|
atazanavir |
1 |
|
atherosclerosis |
1 |
|
atractylodes macrocephala rhizome |
1 |
|
authentication |
1 |
|
autophagy |
1 |
|
azone |
1 |
|
bacillus subtilis |
1 |
|
baicalein |
1 |
|
baihuasheshecao |
1 |
|
bakuchiol |
1 |
|
basilar artery |
1 |
|
bax |
1 |
|
bcl-2 |
1 |
|
berberine |
1 |
|
bevacizumab |
1 |
|
biflavonoids |
1 |
|
bile duct obstruction |
1 |
|
bioactive marker |
1 |
|
biomarkers |
1 |
|
biomedicine |
1 |
|
bisandrographolide |
1 |
|
bisindole |
1 |
|
bisphosphonates |
1 |
|
bitter melon |
1 |
|
black blood |
1 |
|
blood lymphocytes |
1 |
|
bone destruction |
1 |
|
bone metabolism |
1 |
|
bone metastasis |
1 |
|
bone mineral density |
1 |
|
bone resorption |
1 |
|
boron dipyr-romethene |
1 |
|
boron dipyrromethenes |
1 |
|
brain-metastasis |
1 |
|
breast cancer cells |
1 |
|
breast cancer stem cells |
1 |
|
breast neoplasms |
1 |
|
breast tumor |
1 |
|
c. mukul |
1 |
|
caco-2 cells |
1 |
|
caco-2 cells9 |
1 |
|
caffeine |
1 |
|
calculi |
1 |
|
calu-3 |
1 |
|
camellia sinensis |
1 |
|
camellia sinensis (cs) |
1 |
|
cancer stem cells |
1 |
|
cancer stem-like cells |
1 |
|
cancer therapy |
1 |
|
carbohydrate mimics |
1 |
|
carbohydrates |
1 |
|
cardiovascular protection |
1 |
|
carthami flos |
1 |
|
caspase-3 |
1 |
|
caspase-3 biosensor |
1 |
|
cathepsin b, extracellular matrix |
1 |
|
cd4 |
1 |
|
cd8 |
1 |
|
cd81 |
1 |
|
cdna microarry |
1 |
|
cell adhesion |
1 |
|
cell adhesion molecules |
1 |
|
cell invasion |
1 |
|
cell labeling |
1 |
|
cell migration |
1 |
|
cellular apoptosis |
1 |
|
centipeda minima |
1 |
|
cerebral basilar artery |
1 |
|
chemical enhancer |
1 |
|
chemical marker |
1 |
|
chemometrics |
1 |
|
chemopreventive |
1 |
|
children |
1 |
|
chinese herb |
1 |
|
chinese herbal formula |
1 |
|
chinese herbs |
1 |
|
chinese medicine, wound healing |
1 |
|
cholesterol |
1 |
|
chondrogenesis |
1 |
|
cistanche deserticola |
1 |
|
colitis |
1 |
|
colon cancer |
1 |
|
colon cancer cells |
1 |
|
combination |
1 |
|
combination effect |
1 |
|
combination effects |
1 |
|
combination index |
1 |
|
combination therapy |
1 |
|
congenital malformation |
1 |
|
contractility |
1 |
|
controlled-release |
1 |
|
conventional |
1 |
|
conventional medicines |
1 |
|
copd |
1 |
|
cordyceps |
1 |
|
coriolus versicolor (cv) |
1 |
|
cotc analogues |
1 |
|
crataegus fructus |
1 |
|
crc |
1 |
|
cross-coupling |
1 |
|
crystallization |
1 |
|
cucurbitacin |
1 |
|
cucurbitane triterpenoid |
1 |
|
cycasin derivative |
1 |
|
cycloartane triterpenoid |
1 |
|
cyclooxygenase-2 |
1 |
|
cynanchum otophyllum |
1 |
|
cyp1a2 |
1 |
|
cyp2c9 |
1 |
|
cyp2d6 |
1 |
|
cyp2e1 |
1 |
|
cyp3a2 |
1 |
|
cyp3a4 |
1 |
|
cytochrome c |
1 |
|
cytokine |
1 |
|
cytokine response |
1 |
|
cytokines |
1 |
|
cytotoxicity test |
1 |
|
daidzein |
1 |
|
daidzin |
1 |
|
danshen-gegen decoction |
1 |
|
danshensu |
1 |
|
darifenacin |
1 |
|
dearomatized isoprenylated acylphloroglucinols |
1 |
|
dendritic cell |
1 |
|
dendritic cells |
1 |
|
dendrobium officinale kimura & migo |
1 |
|
dendrobium officinale polysaccharide |
1 |
|
dendrobium species |
1 |
|
densitometry |
1 |
|
depside |
1 |
|
dermatophyte |
1 |
|
detrusor overactivity |
1 |
|
detrusor smooth muscle |
1 |
|
development |
1 |
|
dextran sulfate sodium |
1 |
|
diabetes |
1 |
|
diabetes treatments |
1 |
|
diabetic foot |
1 |
|
diabetic foot ulcer endothelial progenitor cells |
1 |
|
diabetic mellitus |
1 |
|
diabetic wound healing |
1 |
|
diastereoselectivity |
1 |
|
dioscorea opposita |
1 |
|
diosmetin |
1 |
|
diosmin |
1 |
|
disuse osteoporosis |
1 |
|
dna barcoding |
1 |
|
dong quai |
1 |
|
drug design |
1 |
|
drug interaction |
1 |
|
drug loading |
1 |
|
drug resistance |
1 |
|
dyeing method |
1 |
|
dysbiosis |
1 |
|
echinacea |
1 |
|
eczema |
1 |
|
efflux |
1 |
|
egcg |
1 |
|
eleutheroside e |
1 |
|
embryotoxic components |
1 |
|
enhanced permeability |
1 |
|
environmental control |
1 |
|
epicatechin gallate |
1 |
|
epigallocatechin |
1 |
|
epimedii herba |
1 |
|
epithelial-to-mesenchymal transition |
1 |
|
erbb signaling pathway |
1 |
|
erigerontis |
1 |
|
erk1/2 |
1 |
|
esophageal neoplasms |
1 |
|
esophageal patient-derived xenografts |
1 |
|
esophageal squamous cell carcinoma |
1 |
|
eucalyptus globules |
1 |
|
extracts |
1 |
|
fascia |
1 |
|
fasciitis |
1 |
|
fasciology |
1 |
|
fat1 |
1 |
|
fatty acid |
1 |
|
fertilizers |
1 |
|
ferulic acid |
1 |
|
fibroblast |
1 |
|
fibroblast proliferation |
1 |
|
fibrosis |
1 |
|
flavone |
1 |
|
folium isatidis |
1 |
|
folium mori |
1 |
|
food contamination |
1 |
|
foot ulcer |
1 |
|
foot ulcer animal model |
1 |
|
foot ulcers |
1 |
|
formononetin |
1 |
|
foxo signaling pathway |
1 |
|
fracture |
1 |
|
fracture healing |
1 |
|
fructus corni |
1 |
|
fructus schisandrae |
1 |
|
fructus schisandrae chinensis |
1 |
|
g protein-coupled receptors |
1 |
|
ganoderma lucidum |
1 |
|
ganoderma spores |
1 |
|
garcinia xanthochymus |
1 |
|
gastric injury |
1 |
|
gastrointestinal microbiome |
1 |
|
gemcitabine |
1 |
|
gene expression |
1 |
|
gentamicin and fusidic acid resistance |
1 |
|
gentianopsis paludosa |
1 |
|
ginseng |
1 |
|
glucose |
1 |
|
glycoproteins |
1 |
|
grains |
1 |
|
granulation tissue |
1 |
|
green tea |
1 |
|
gut microbiome |
1 |
|
gut microbiota |
1 |
|
h9c2 |
1 |
|
hazardous waste |
1 |
|
hcp-2 |
1 |
|
hct116 |
1 |
|
hct116 cells |
1 |
|
hda |
1 |
|
healthcare textiles |
1 |
|
her2-positive breast cancer |
1 |
|
herb-drug interaction |
1 |
|
herba |
1 |
|
herba cistanches |
1 |
|
herba patriniae |
1 |
|
herbal |
1 |
|
herbal extract |
1 |
|
herbal material |
1 |
|
herbal therapy |
1 |
|
herbal topical therapy |
1 |
|
herbs |
1 |
|
herb–drug interaction |
1 |
|
heteronone |
1 |
|
high performance liquid chromatography |
1 |
|
high-speed counter-current chromatography |
1 |
|
hind limb unloading |
1 |
|
hindlimb ischemia |
1 |
|
hmec-1 |
1 |
|
houttuynia cordata |
1 |
|
ht-29 cells |
1 |
|
human epidermal growth factor receptor 2 (her2) |
1 |
|
human liver microsomes |
1 |
|
human microvascular endothelial cells |
1 |
|
human peripheral blood mononuclear cells |
1 |
|
human skin fibroblast cells hs27 |
1 |
|
human t-cell density |
1 |
|
hydrogel matrix |
1 |
|
hydroxyapatite |
1 |
|
hydroxylated enones |
1 |
|
hypericaceae |
1 |
|
hypericin |
1 |
|
hypericum |
1 |
|
hypericum ascyron linn. |
1 |
|
hyperlipidemia |
1 |
|
hypnotic effects |
1 |
|
hypoglycemic mechanism |
1 |
|
il6/stat3 pathway |
1 |
|
immune modulation |
1 |
|
immunological activity |
1 |
|
immunological adjuvant |
1 |
|
immunomodulating effect |
1 |
|
immunomodulation |
1 |
|
immunomodulatory |
1 |
|
immunomodulatory effects |
1 |
|
immunostimulatory |
1 |
|
immunostimulatory effects |
1 |
|
immunosuppression |
1 |
|
in vitro tests |
1 |
|
inducible nitric oxide synthase |
1 |
|
inflammatory |
1 |
|
inhibited cell proliferation |
1 |
|
inhibitors |
1 |
|
insulin resistance |
1 |
|
interleukin-12 |
1 |
|
interleukin-2 |
1 |
|
interleukin-6 |
1 |
|
internal transcribed spacer (its) |
1 |
|
inula helianthus-aquatica |
1 |
|
ion transport |
1 |
|
iridoid glycoside |
1 |
|
isoflavonoid |
1 |
|
isofraxidin |
1 |
|
isothermal amplification |
1 |
|
jaboticaba |
1 |
|
jaboticabin |
1 |
|
k/s value |
1 |
|
kaempferia galangal |
1 |
|
keratinocyte proliferation |
1 |
|
kidney |
1 |
|
kuguacins ii-vi |
1 |
|
kuraridin |
1 |
|
labdane diterpenoids |
1 |
|
largehead atractylodes rhizome |
1 |
|
lc-ms |
1 |
|
lc-qtof-ms |
1 |
|
leguminosae |
1 |
|
leojapone |
1 |
|
leonurus japonicus |
1 |
|
lewis lung cancer |
1 |
|
liang miao san |
1 |
|
lighting condition |
1 |
|
ligustilide |
1 |
|
ligustri lucidi fructus |
1 |
|
lingzhine c |
1 |
|
linoleic acid |
1 |
|
liquid chromatography-mass spectrometry |
1 |
|
liver |
1 |
|
loop-mediated isothermal amplification |
1 |
|
lymphocytes |
1 |
|
lymphoma |
1 |
|
macrocarpal c |
1 |
|
macrophage |
1 |
|
macrophages |
1 |
|
magnetic nanoparticle |
1 |
|
mapk pathways |
1 |
|
mast cell |
1 |
|
mast cells |
1 |
|
mdr |
1 |
|
mechanism |
1 |
|
medicinal botanicals |
1 |
|
medicinal grains |
1 |
|
medicinal herbs |
1 |
|
medicinal mushrooms |
1 |
|
melodinine v |
1 |
|
membrane permeability |
1 |
|
menopause |
1 |
|
mesenchymal stem cell |
1 |
|
metabolic syndrome |
1 |
|
metastasis, tumor microenvironment |
1 |
|
metastatic breast cancer |
1 |
|
methicillin resistant staphylococcus aureus |
1 |
|
methicillin resistant staphylococcus aureus (mrsa) |
1 |
|
methicillin-resistant staphylococcus aureus (mrsa) |
1 |
|
method establishment study |
1 |
|
methylene blue |
1 |
|
metronomic |
1 |
|
metronomic dose |
1 |
|
micro-architecture |
1 |
|
microarray |
1 |
|
microbiome |
1 |
|
microbiota |
1 |
|
microenvironment |
1 |
|
milk thistle |
1 |
|
molecular authentication |
1 |
|
mordant dyeing |
1 |
|
morphology feature |
1 |
|
moslosooflavone |
1 |
|
moutan cortex |
1 |
|
mscs |
1 |
|
mtor |
1 |
|
mtor signaling |
1 |
|
multi-targeted |
1 |
|
muscle toxicity |
1 |
|
mycobacteria |
1 |
|
myelosuppression |
1 |
|
myrciaria cauliflora |
1 |
|
myrtaceae |
1 |
|
na -glucose cotransporter + |
1 |
|
naringenin |
1 |
|
naringin |
1 |
|
natural flavone |
1 |
|
neoplastic stem cells |
1 |
|
network pharmacology |
1 |
|
neurotrophic activity |
1 |
|
neutral and weakly acidic water-soluble extract |
1 |
|
nfκb |
1 |
|
nitric oxide |
1 |
|
non-alcoholic fatty liver |
1 |
|
non-alcoholic fatty liver disease |
1 |
|
nora |
1 |
|
norviburtinal |
1 |
|
obesity |
1 |
|
obesity-associated colorectal cancer |
1 |
|
oleic acid |
1 |
|
oligosaccharide |
1 |
|
onosma dichroantha |
1 |
|
orthogonal array |
1 |
|
orthogonal array analysis |
1 |
|
orthotopic mouse model |
1 |
|
osteoclast |
1 |
|
osteoclastogenesis |
1 |
|
osteogenesis |
1 |
|
osteolysis |
1 |
|
osteoporosis |
1 |
|
osteoprotegerin |
1 |
|
overall survival |
1 |
|
oxidative damage |
1 |
|
p. corylifolia |
1 |
|
p2-2 |
1 |
|
paenonia suffruticosa |
1 |
|
paeoniflorin |
1 |
|
paeonol |
1 |
|
palladium |
1 |
|
palliative management |
1 |
|
panicolin |
1 |
|
pathways |
1 |
|
patient-derived xenografts |
1 |
|
patrinia heterophylla |
1 |
|
patrinia villosa |
1 |
|
patriniae herba |
1 |
|
pca |
1 |
|
pcr array |
1 |
|
pectic polysaccharide |
1 |
|
penta herb formula |
1 |
|
pentaherb formula |
1 |
|
pentaherbs |
1 |
|
pentaherbs formula |
1 |
|
people's republic of china |
1 |
|
pepck activity |
1 |
|
percutaneous behavior |
1 |
|
peripheral blood mononuclear cells |
1 |
|
peripheral blood mononuclear cells (pbmcs) |
1 |
|
pharmacodynamic interaction |
1 |
|
pharmacokinetic interaction |
1 |
|
phenolic extract |
1 |
|
photosensitizer |
1 |
|
phthalocyanine |
1 |
|
pinocembrin |
1 |
|
pistillarin |
1 |
|
plant factory |
1 |
|
plants |
1 |
|
pleurotus tuber-regium |
1 |
|
poaceae |
1 |
|
poloxamer hydrogel |
1 |
|
polycyclic polyprenylated acylphloroglucinols |
1 |
|
polygala tenuifolia |
1 |
|
polygonum multiflorum |
1 |
|
polysaccharides and phenolic compounds |
1 |
|
poria |
1 |
|
poria cocos |
1 |
|
porous structure |
1 |
|
postprandial hyperglycemia |
1 |
|
primary breast cancer cells |
1 |
|
pro-angiogenesis |
1 |
|
proliferation |
1 |
|
propolis |
1 |
|
proprietary chinese medicines |
1 |
|
prostaglandin e2 |
1 |
|
psk |
1 |
|
psoralea corylifolia |
1 |
|
psoraleae fructus |
1 |
|
puerariae lobatae radix |
1 |
|
puerarin |
1 |
|
pyruvate kinase |
1 |
|
r-hepg2 |
1 |
|
ra-v |
1 |
|
ra-xii |
1 |
|
rabbit closed fracture model |
1 |
|
radix achyranthis bidentatae |
1 |
|
radix cyathulae |
1 |
|
radix ophiopogonis |
1 |
|
raloxifene |
1 |
|
rankl |
1 |
|
raw264.7 cells |
1 |
|
rehmapicrogenin |
1 |
|
release kinetic |
1 |
|
reproductive toxicity |
1 |
|
respiratory tract pathology |
1 |
|
rhein |
1 |
|
rheumatoid arthritis |
1 |
|
rhizoma alismatis |
1 |
|
rhizoma dioscoreae |
1 |
|
rna microarray |
1 |
|
rna-dependent rna polymerase |
1 |
|
ros production |
1 |
|
rosuvastatin |
1 |
|
rubia yunnanensis |
1 |
|
s. canadensis |
1 |
|
safety evaluation |
1 |
|
sarcoma |
1 |
|
sars-cov-2 |
1 |
|
schisandrae chinensis fructus |
1 |
|
schisandrae fructus |
1 |
|
schizandrin |
1 |
|
selective cytotoxicity |
1 |
|
senkyunolide a |
1 |
|
seropharmacology |
1 |
|
sglt |
1 |
|
sglt2 |
1 |
|
sh formula |
1 |
|
short-circuit current |
1 |
|
si wu tang |
1 |
|
si-wu-tang |
1 |
|
signal transduction |
1 |
|
simvastatin |
1 |
|
sinomenine |
1 |
|
skin wound infections |
1 |
|
slco1b1 |
1 |
|
small molecule fingerprint-analysis |
1 |
|
sophora flavescens |
1 |
|
soy isoflavones |
1 |
|
spice |
1 |
|
spirocyclic polyprenylated acylphloroglucinols |
1 |
|
spontaneously hypertensive rat |
1 |
|
spontaneously hypertensive rat (shr) |
1 |
|
staphylococcus aureus |
1 |
|
statin |
1 |
|
stem cells |
1 |
|
stroke |
1 |
|
structural characterization |
1 |
|
structure analysis |
1 |
|
structure character |
1 |
|
sub-intestinal vessel |
1 |
|
surface modification |
1 |
|
swelling inflammation |
1 |
|
synthesis |
1 |
|
syringin |
1 |
|
systolic blood pressure |
1 |
|
t helper cytokines |
1 |
|
t1rho (t1ρ) |
1 |
|
tail-suspension |
1 |
|
target prediction |
1 |
|
tendonitis |
1 |
|
tetrasapanin |
1 |
|
thermal hydrolysis |
1 |
|
thermosensitive hydrogel |
1 |
|
thermosensitive hydrogel therapy |
1 |
|
thin-layer chromatography |
1 |
|
thiols |
1 |
|
three-herbs formula |
1 |
|
tibetan medicine |
1 |
|
tie2 |
1 |
|
tinea pedis |
1 |
|
tissue engineering |
1 |
|
titanium alloy |
1 |
|
toll-like receptor-4 |
1 |
|
topical agent |
1 |
|
topical application |
1 |
|
topical treatment |
1 |
|
trachea |
1 |
|
traditional chinese medicines |
1 |
|
traditional medicine |
1 |
|
trans-ethyl p-methoxycinnamate |
1 |
|
transdermal absorption |
1 |
|
transdermal drug delivery |
1 |
|
transdermal therapy |
1 |
|
transformation growth factor |
1 |
|
trichophyton mentagrophytes |
1 |
|
triple negative breast cancer |
1 |
|
triple therapy |
1 |
|
triticum aestivu |
1 |
|
tuberculosis |
1 |
|
tumor microenvironment |
1 |
|
tumor necrosis factor-α |
1 |
|
tumor recurrence |
1 |
|
tumorigenicity |
1 |
|
turmeric |
1 |
|
turmeric extract |
1 |
|
type 2 diabetes |
1 |
|
ulcer healing |
1 |
|
uplc-qtof-ms |
1 |
|
valerosidate |
1 |
|
vascular endothelial growth factor (vegf) |
1 |
|
vascular endothelial growth factor receptor 2 (vegfr-2) |
1 |
|
vasodilatation |
1 |
|
vegf |
1 |
|
warfarin |
1 |
|
wound infection model |
1 |
|
wound measurement |
1 |
|
xanthone |
1 |
|
z-ligustilide |
1 |
|
zebrafish embryos |
1 |
|
zebrafish model |
1 |
|
zerumin a |
1 |
|
zingiberaceae |
1 |
|
ziziphus jujube |
1 |
|
zoledronate |
1 |
|
β-1,4-mannan |
1 |
|
β-glucan |
1 |
